These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7076786)

  • 21. Optimizing subgroup selection in two-stage adaptive enrichment and umbrella designs.
    Ballarini NM; Burnett T; Jaki T; Jennison C; König F; Posch M
    Stat Med; 2021 May; 40(12):2939-2956. PubMed ID: 33783020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bayesian non-inferiority test for two independent binomial proportions.
    Kawasaki Y; Miyaoka E
    Pharm Stat; 2013; 12(4):201-6. PubMed ID: 23625633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines.
    Bittl JA; He Y
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive checking for Bayesian interim analyses in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Sep; 29(5):740-50. PubMed ID: 18571477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From P-Values to Objective Probabilities in Assessing Medical Treatments.
    Kault D; Kault S
    PLoS One; 2015; 10(11):e0142132. PubMed ID: 26600468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Problems and advantages of an observational data base approach to evaluating the effect of therapy on outcome.
    Rosati RA; Lee KL; Califf RM; Pryor DB; Harrell FE
    Circulation; 1982 Jun; 65(7 Pt 2):27-32. PubMed ID: 7044604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Bayesian statistics to estimate the likelihood a new trial will demonstrate the efficacy of a new treatment.
    Biau DJ; Boulezaz S; Casabianca L; Hamadouche M; Anract P; Chevret S
    BMC Med Res Methodol; 2017 Aug; 17(1):128. PubMed ID: 28830464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selected topics in statistical analysis of clinical research.
    Baer L; Ahern DK
    J Geriatr Psychiatry Neurol; 1989; 2(1):34-40. PubMed ID: 2663014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian credible subgroups approach to identifying patient subgroups with positive treatment effects.
    Schnell PM; Tang Q; Offen WW; Carlin BP
    Biometrics; 2016 Dec; 72(4):1026-1036. PubMed ID: 27159131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian population finding with biomarkers in a randomized clinical trial.
    Morita S; Müller P
    Biometrics; 2017 Dec; 73(4):1355-1365. PubMed ID: 28257141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?
    Iorio A; Marcucci M
    Haemophilia; 2009 Jul; 15(4):900-3. PubMed ID: 19473413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interim analyses in clinical trials: classical vs. Bayesian approaches.
    Berry DA
    Stat Med; 1985; 4(4):521-6. PubMed ID: 4089353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Roaming through methodology. XXXVI. Likelihood ratios and Bayes' rule].
    Vermeulen M
    Ned Tijdschr Geneeskd; 2001 Dec; 145(50):2421-4. PubMed ID: 11776667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2004 Jun; 43(11):1929-39. PubMed ID: 15172393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust Bayesian methods for monitoring clinical trials.
    Greenhouse JB; Wasserman L
    Stat Med; 1995 Jun; 14(12):1379-91. PubMed ID: 7569495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting posterior probabilities in Bayesian analyses of clinical trials.
    Yarnell CJ; Goligher EC
    Lancet Respir Med; 2024 Mar; 12(3):188-190. PubMed ID: 38043566
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bayesian thinking on its way into medical statistics?].
    Aursnes I; Natvig B; Tvete IF
    Tidsskr Nor Laegeforen; 2002 May; 122(14):1369-72. PubMed ID: 12098906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.